GLP-1 use for obesity started significantly increasing from about 2020. 4% of Americans were (officially) taking them by 2024. Add on the unofficial numbers, plus the fact that weight loss with the drug still takes months to years, and it probably is a very big factor, if not the factor.
This looks more like the spread of GLP-1s. Food insecurity has been just as high in the recent past while the obesity rate was increasing.
Nope that only got big 2 years ago.
I guess there is a second downwards bend that might be explained by ozempic.
GLP-1 use for obesity started significantly increasing from about 2020. 4% of Americans were (officially) taking them by 2024. Add on the unofficial numbers, plus the fact that weight loss with the drug still takes months to years, and it probably is a very big factor, if not the factor.